GSK plc (LON:GSK) Receives Average Rating of “Hold” from Brokerages

GSK plc (LON:GSK) has been given an average recommendation of “Hold” by the seven research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is GBX 1,675.63 ($21.05).

Several equities research analysts have recently issued reports on the company. Shore Capital reaffirmed a “buy” rating on shares of GSK in a research note on Wednesday, May 1st. Berenberg Bank lifted their price objective on shares of GSK from GBX 1,650 ($20.73) to GBX 1,820 ($22.86) and gave the stock a “buy” rating in a research note on Wednesday, February 14th. JPMorgan Chase & Co. increased their target price on shares of GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the company an “underweight” rating in a research note on Thursday, May 2nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,950 ($24.50) price target on shares of GSK in a report on Wednesday, April 17th. Finally, Barclays reissued an “equal weight” rating and issued a GBX 1,725 ($21.67) price objective on shares of GSK in a research note on Tuesday.

GSK Stock Up 0.7 %

Shares of GSK stock opened at GBX 1,773.50 ($22.28) on Thursday. The company’s fifty day simple moving average is GBX 1,666.29 and its two-hundred day simple moving average is GBX 1,562.88. GSK has a 52 week low of GBX 1,302.60 ($16.36) and a 52 week high of GBX 1,776 ($22.31). The stock has a market cap of £72.54 billion, a P/E ratio of 1,477.92, a PEG ratio of 1.12 and a beta of 0.27. The company has a quick ratio of 0.73, a current ratio of 0.88 and a debt-to-equity ratio of 140.82.

GSK Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, July 11th. Stockholders of record on Thursday, May 16th will be issued a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 0.9%. The ex-dividend date is Thursday, May 16th. GSK’s dividend payout ratio (DPR) is presently 5,333.33%.

Insider Buying and Selling

In related news, insider Urs Rohner purchased 434 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were bought at an average cost of GBX 1,662 ($20.88) per share, with a total value of £7,213.08 ($9,061.66). In other news, insider Emma Walmsley sold 139,792 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.83), for a total transaction of £2,317,751.36 ($2,911,747.94). Also, insider Urs Rohner bought 434 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were acquired at an average price of GBX 1,662 ($20.88) per share, for a total transaction of £7,213.08 ($9,061.66). Corporate insiders own 1.77% of the company’s stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.